EGFR and c-Met inhibitors as factors limiting formation of invadopodia in human melanoma cells

2014/15/B/NZ5/01467

Keywords

Descriptors

  • NZ5_3: Patogeneza chorób człowieka
  • NZ5_5: Diagnostyka chorób człowieka
  • NZ5_7: Leczenie chorób człowieka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Uniwersytet Wrocławski, Wydział Biotechnologii

Voivodeship: dolnośląskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Dorota Nowak

Number of co-investigators in the project: 4

Call

OPUS 8 – announced on 2014-09-15

Amount awarded
634 940 PLN
Project start date
2015-07-22
Project end date
2019-07-21
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. Pojemnik do przechowywania próbek w ciekłym azocie. Cost: 20 000 PLN
  2. Zamrażarka niskotemperaturowa. Cost: 51 000 PLN
  3. system do elektroforezy białkowej i transferu białek metodą Western Blotting.

Information in the final report

Publication in academic press/journals (5)

  1. Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment.

    Authors:
    Dratkiewicz Ewelina, Simiczyjew Aleksandra, Pietraszek-Gremplewicz Katarzyna, Mazurkiewicz Justyna, Nowak Dorota.
    Academic press:
    International Journal of Molecular Sciences (year: 2020, volume: 21, pages: 113), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms21010113 – link to the publication
  2. Expression level of EGFR and MET receptors regulates invasiveness of melanoma cells

    Authors:
    Katarzyna Pietraszek-Gremplewicz, Aleksandra Simiczyjew, Ewelina Dratkiewicz, Marta Podgórska, Ilona Styczeń, Rafał Matkowski, Marcin Ziętek, Dorota Nowak
    Academic press:
    Journal of Cellular and Molecular Medicine (year: 2019, volume: 23, pages: 8453–8463), Publisher: Wiley-Blackwell
    Status:
    Published
    DOI:
    10.1111/jcmm.14730 – link to the publication
  3. Varying effects of EGF, HGF and TGFBeta on formation of invadopodia and invasiveness of melanoma cell lines of different origin.

    Authors:
    Makowiecka A., Simiczyjew A., Nowak D., Mazur A. J.
    Academic press:
    European Journal of Histochemistry (year: 2016, volume: 60, pages: 230-238), Publisher: PagePress
    Status:
    Published
    DOI:
    10.4081/ejh.2016.2728 – link to the publication
  4. Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines

    Authors:
    Ewelina Dratkiewicz, Katarzyna Pietraszek-Gremplewicz, Aleksandra Simiczyjew, Antonina Joanna Mazur, Dorota Nowak
    Academic press:
    Oncotarget (year: 2018, volume: Vol.9 (No26), pages: 18254-18268), Publisher: Impact Journal LLC
    Status:
    Published
    DOI:
    10.18632/oncotarget.24810 – link to the publication
  5. Combination of selected MET and EGFR inhibitors decreases melanoma cells' invasive abilities

    Authors:
    Aleksandra Simiczyjew, Katarzyna Pietraszek-Gremplewicz, Ewelina Dratkiewicz, Marta Podgórska, Rafał Matkowski, Marcin Ziętek, Dorota Nowak
    Status:
    Accepted for publication

Articles in post-conference publications (4)

  1. Effect of EGFR and c-Met inhibitors on melanoma viability, cell cycle and migration

    Authors:
    Ewelina Dratkiewicz, Aleksandra Simiczyjew, Katarzyna Pietraszek-Gremplewicz, Dorota Nowak
    Conference:
    FEBS Advanced Lecture Course and European Cytoskeletal Forum Meeting / Cytoskeleton: Mechanical Coupling from the Plasma Membrane to Nucleus (year: 2017, pages: str. 64), Publisher: FEBS
    Date:
    conference 04-08.2017
    Status:
    Published
  2. Foretinib in combination with lapatinib orgefitinib reduces invasion of melanoma cells.

    Authors:
    Simiczyjew S., Pietraszek-Gremplewicz K., Dratkiewicz E., Podgóorska M., Matkowski R., Ziętek M., Nowak D.
    Conference:
    FEBS Congress (year: 2019, pages: 194), Publisher: FEBS press
    Date:
    conference 6-11.07.2019
    Status:
    Published
  3. Melanoma cells resistant to vemurafenib exhibited changes in expression profile of growth factor receptors and elevated invasive abilities.

    Authors:
    Dratkiewicz E., Simiczyjew A, Pietraszek-Gremplewicz K., Nowak D.
    Conference:
    FEBS Congress (year: 2019, pages: 358), Publisher: FEBS press
    Date:
    conference 6-11.07.2019
    Status:
    Published
  4. Vemurafenib-resistant melanoma cells demonstrate altered invadopodia and changes in sensitivity to EGFR and c-Met inhibitors

    Authors:
    Dratkiewicz E., Simiczyjew A., Pietraszek-Gremplewicz K., Nowak D.
    Conference:
    Congress BIO2018 (year: 2018, pages: 93), Publisher: Polskie Towarzystwo Biochemiczne i Komitet Biochemii i Biofizyki PAN
    Date:
    conference 18-21.09.2018
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski